Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Regeneron and SocietyforScience
Shared 2 weeks ago
174 views
Regeneron and SocietyforScience
Shared 3 weeks ago
2.4K views
Regeneron and SocietyforScience
Shared 4 weeks ago
629 views
Regeneron and SocietyforScience
Shared 4 weeks ago
2.4K views
Regeneron and SocietyforScience
Shared 4 weeks ago
816 views
Shared 1 month ago
473K views
Regeneron and SocietyforScience
Shared 1 month ago
1.9K views
Shared 1 month ago
164 views
Shared 1 month ago
66 views
Shared 3 months ago
155 views
Shared 3 months ago
427 views
Shared 4 months ago
233 views
Shared 5 months ago
342 views
Shared 5 months ago
136 views
Shared 6 months ago
41K views
Shared 6 months ago
201 views
Shared 6 months ago
103K views
Shared 9 months ago
745 views
Shared 9 months ago
148 views
Shared 10 months ago
440 views
Shared 10 months ago
18K views
Shared 10 months ago
23K views
Shared 10 months ago
305 views
Shared 1 year ago
598 views
Shared 1 year ago
410 views
Shared 1 year ago
307 views
Shared 1 year ago
345 views
Shared 1 year ago
409 views
Shared 1 year ago
429 views
Shared 1 year ago
3.3M views
Shared 1 year ago
234 views
Shared 1 year ago
1.7K views
Shared 2 years ago
419K views